Literature DB >> 20436163

Tumor necrosis factor and anti-tumor necrosis factor therapies.

Edward C Keystone1, Carl F Ware.   

Abstract

Tumor necrosis factor (TNF) plays a crucial role in the pathogenesis of immune-mediated inflammatory diseases (IMID). As a result, the inhibition of TNF is an important therapeutic avenue in the treatment of these pathophysiologically diverse disease states. This section discusses TNF, its receptors, and its role in immunoregulation and inflammation, as well as the currently available anti-TNF-based therapies.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20436163     DOI： 10.3899/jrheum.091463

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  23 in total

1.  Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort.

Authors:  João D Fontes; Faisal Rahman; Sean Lacey; Martin G Larson; Ramachandran S Vasan; Emelia J Benjamin; William S Harris; Sander J Robins
Journal:  Atherosclerosis       Date:  2015-04-03       Impact factor: 5.162

2.  The immunologically active oligosaccharides isolated from wheatgrass modulate monocytes via Toll-like receptor-2 signaling.

Authors:  Chia-Che Tsai; Chih-Ru Lin; Hsien-Yu Tsai; Chia-Jung Chen; Wen-Tai Li; Hui-Ming Yu; Yi-Yu Ke; Wei-Ying Hsieh; Cheng-Yen Chang; Ying-Ta Wu; Chung-Yi Wu; Shui-Tein Chen; Chi-Huey Wong
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

3.  TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species.

Authors:  Francisco J Roca; Lalita Ramakrishnan
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

4.  TNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2.

Authors:  Wagdi Almishri; Tania Santodomingo-Garzon; Tyson Le; Danuta Stack; Christopher H Mody; Mark G Swain
Journal:  J Innate Immun       Date:  2016-08-25       Impact factor: 7.349

Review 5.  Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Authors:  Naoki Yoshimura; Tomohiko Oguchi; Hitoshi Yokoyama; Yasuhito Funahashi; Satoru Yoshikawa; Yoshio Sugino; Naoki Kawamorita; Mahendra P Kashyap; Michael B Chancellor; Pradeep Tyagi; Teruyuki Ogawa
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

6.  Vasculitis associated with tumor necrosis factor-α inhibitors.

Authors:  Olayemi Sokumbi; David A Wetter; Ashima Makol; Kenneth J Warrington
Journal:  Mayo Clin Proc       Date:  2012-07-13       Impact factor: 7.616

7.  The impact of glycosylation on the pharmacokinetics of a TNFR2:Fc fusion protein expressed in Glycoengineered Pichia Pastoris.

Authors:  Liming Liu; Sujatha Gomathinayagam; Lora Hamuro; Thomayant Prueksaritanont; Weirong Wang; Terrance A Stadheim; Stephen R Hamilton
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

Review 8.  Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2010-07-29       Impact factor: 4.546

9.  Emerging patterns of genetic overlap across autoimmune disorders.

Authors:  Corinne Richard-Miceli; Lindsey A Criswell
Journal:  Genome Med       Date:  2012-01-27       Impact factor: 11.117

Review 10.  PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2012-11-15       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.